C561-0571 Screening compound: N-[(4-chlorophenyl)methyl]-3-[2-(3,5-dimethoxyphenyl)-5,7-dimethylpyrazolo[1,5-a]pyrimidin-6-yl]propanamide

C561-0571 Screening compound: N-[(4-chlorophenyl)methyl]-3-[2-(3,5-dimethoxyphenyl)-5,7-dimethylpyrazolo[1,5-a]pyrimidin-6-yl]propanamide
C561-0571 Screening compound: N-[(4-chlorophenyl)methyl]-3-[2-(3,5-dimethoxyphenyl)-5,7-dimethylpyrazolo[1,5-a]pyrimidin-6-yl]propanamide alternative view

Chemical Structure Depiction of ChemDiv screening compound C561-0571
N-[(4-chlorophenyl)methyl]-3-[2-(3,5-dimethoxyphenyl)-5,7-dimethylpyrazolo[1,5-a]pyrimidin-6-yl]propanamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

C561-0571

Molecular Formula

C26H27ClN4O3 (C26 H27 ClN4 O3)

Compound Name

N-[(4-chlorophenyl)methyl]-3-[2-(3,5-dimethoxyphenyl)-5,7-dimethylpyrazolo[1,5-a]pyrimidin-6-yl]propanamide

IUPAC name

N-[(4-chlorophenyl)methyl]-3-[2-(35-dimethoxyphenyl)-57-dimethylpyrazolo[15-a]pyrimidin-6-yl]propanamide

SMILES

Cc1c(CCC(NCc(cc2)ccc2Cl)=O)c(C)nc2cc(-c3cc(OC)cc(OC)c3)nn12

InChI

InChI=1S/C26H27ClN4O3/c1-16-23(9-10-26(32)28-15-18-5-7-20(27)8-6-18)17(2)31-25(29-16)14-24(30-31)19-11-21(33-3)13-22(12-19)34-4/h5-8,11-14H,9-10,15H2,1-4H3,(H,28,32)

InChI Key

KOUBDGJSNIJJTD-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD14770236

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

478.98

Hydrogen Bond Acceptors Count

6.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

9.00

Number of Nitrogen and Oxygen Atoms

7

Partition Coefficient, logP

4.628

Distribution Coefficient, logD

4.598

Water Solubility, LogSw

-4.78

Polar Surface Area

59.008

Acid Dissociation Constant (pKa)

12.45

Base Dissociation Constant (pKb)

6.26

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

26.90

C561-0571 in Drug Discovery

Included in Screening Libraries

3D-Biodiversity Library (27607 compounds)

Antiviral Annotated Library (21441 compounds)

Immunological Library (6760 compounds)

Serine Proteases Inhibitors Library (32732 compounds)

ChemoGenomic Annotated Library for Phenotypic Screening (89798 compounds)

Target Identification, Phenotypic Screening library (TIPS) (27612 compounds)

Included in 1.7M Stock Database

Structure:
  • 3D
Therapeutical areas:
  • Immune system
  • Infections
  • Cancer
  • Musculoskeletal
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Cardiovascular
  • Skin
  • Metabolic
  • Immune system
Targets:
  • Proteases

References: we are preparing a list of scientific research reports with C561-0571 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound C561-0571?
Check Price and Availability of C561-0571, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of C561-0571 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for C561-0571
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for C561-0571
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of C561-0571 available by request